United States Cardiac Rhythm Management Market Size, Share, Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast To 2020 GlobalData's new report, "United States Cardiac Rhythm Management Market Outlook to 2020", provides key market data on the United States Cardiac Rhythm Management Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Cardiac Resynchronisation Therapy (Defibrillators and Pacemakers), Implantable Cardioverter Defibrillators, Implantable Loop Recorders and Pacemakers. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Cardiac Rhythm Management Market wherever available. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. For further information on this report, please visit http://www.radiantinsights.com/research/united-states-cardiac-rhythm-managementmarket-outlook-to-2020 The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Market size for Cardiac Rhythm Management Devices categories - Cardiac Resynchronisation Therapy, Implantable Cardioverter Defibrillators, Implantable Loop Recorders and Pacemakers.
- Annualized market revenue (USD million), volume (units) and average selling price ($) data for the market categories. Data is provided from 2005 to 2012 and forecast to 2020. - 2012 company shares and distribution shares data for the market category. - Global corporate-level profiles of key companies operating within the United States Cardiac Rhythm Management Devices market. - Key players covered include Medtronic, Inc., St. Jude Medical, Inc., Boston Scientific Corporation and BIOTRONIK SE & Co. KG. Reasons to buy - Develop business strategies by identifying the key market categories and segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize. Table Of Content: 1 Table of Contents 2 1.1 List of Tables 7 1.2 List of Figures 8 Request Free Sample Of This Study @ http://www.radiantinsights.com/research/unitedstates-cardiac-rhythm-management-market-outlook-to-2020#tabs-4 2 Introduction 9 2.1 What Is This Report About? 9 2.2 Cardiac Rhythm Management Market Segmentation 9 2.3 Definitions of Markets Covered in the Report 10 3 Cardiac Rhythm Management Market, United States 12 3.1 Cardiac Rhythm Management Market, United States, Revenue ($m), 2005-2012 12 3.2 Cardiac Rhythm Management Market, United States, Revenue ($m), 2012-2020 14 3.2.1 Cardiac Resynchronisation Therapy Market, United States, Revenue ($m), by Segment, 2005-2012 16 3.2.2 Implantable Cardioverter Defibrillators Market, United States, Revenue ($m), by Segment, 2005-2012 18 3.2.3 Pacemakers Market, United States, Revenue ($m), by Segment, 2005-2012 20 3.2.4 Cardiac Resynchronisation Therapy Market, United States, Revenue ($m), by Segment, 2012-2020 22 3.2.5 Implantable Cardioverter Defibrillators Market, United States, Revenue ($m), by Segment, 2012-2020 24
3.2.6 Pacemakers Market, United States, Revenue ($m), by Segment, 2012-2020 26 3.3 Cardiac Rhythm Management Market, United States, Volume (Units), 2005-2012 28 3.4 Cardiac Rhythm Management Market, United States, Volume (Units), 2012-2020 30 3.4.1 Cardiac Resynchronisation Therapy Market, United States, Volume (Units), by Segment, 2005-2012 32 3.4.2 Implantable Cardioverter Defibrillators Market, United States, Volume (Units), by Segment, 2005-2012 34 3.4.3 Pacemakers Market, United States, Volume (Units), by Segment, 2005-2012 36 3.4.4 Cardiac Resynchronisation Therapy Market, United States, Volume (Units), by Segment, 2012-2020 38 3.4.5 Implantable Cardioverter Defibrillators Market, United States, Volume (Units), by Segment, 2012-2020 40 3.4.6 Pacemakers Market, United States, Volume (Units), by Segment, 2012-2020 42 3.5 Cardiac Rhythm Management Market, United States, Average Price ($), 2005-2020 44 3.6 Cardiac Rhythm Management Market, United States, Distribution Share by Revenue ($m), 2011-2012 46 3.7 Cardiac Rhythm Management Market, United States, Company Share by Revenue ($m), 2011-2012 47 Browse Our More Medical Devices Related Reports @ http://www.radiantinsights.com/catalog/medical-devices 4 Overview of Key Companies in United States, Cardiac Rhythm Management Market 49 4.1 Medtronic, Inc. 49 4.1.1 Company Overview 49 4.2 St. Jude Medical, Inc. 49 4.2.1 Company Overview 49 4.3 Boston Scientific Corporation 49 4.3.1 Company Overview 49 4.4 Biotronik SE & Co. KG 50 4.4.1 Company Overview 50 4.5 Sorin S.p.A. 50 4.5.1 Company Overview 50 5 Cardiac Rhythm Management Market Pipeline Products 51 6 Financial Deals Landscape 52 6.1 Acquisition 52 6.1.1 Merit Medical Completes Acquisition Of Thomas Medical From GE Healthcare For Up To US$167 Million 52 6.2 Debt Offerings 54 6.2.1 Medtronic Completes Public Offering Of Notes Due 2017 For US$250 Million 54 6.2.2 Medtronic Completes Public Offering Of 0.875% Notes Due 2017 For US$250 Million 56 6.2.3 Medtronic Completes Public Offering Of Notes Due 2024 For US$850 Million 58 6.2.4 Medtronic Completes Public Offering Of Notes Due 2044 For US$650 Million 60
6.2.5 Medtronic Completes Public Offering Of Notes Due 2018 For US$1 Billion 62 6.2.6 Medtronic Completes Public Offering Of Notes Due 2043 For US$750 Million 64 6.2.7 Medtronic Completes Public Offering Of Notes Due 2023 For US$1.25 Billion 66 6.3 Equity Offerings 68 6.3.1 Stereotaxis Files Registration Statement For Public Offering Of Securities For Up To US$75 Million 68 6.3.2 Stereotaxis Completes Rights Offering Of Shares For US$10.2 Million 69 6.4 Partnerships 70 6.4.1 ZOLL Medical Enters Into Licensing Agreement With Inovise Medical 70 6.5 Venture Financing 71 6.5.1 Rijuven Raises US$0.3 Million In Venture Financing 71 6.5.2 iRhythm Technologies Raises US$16 Million In Series D Financing 72 6.5.3 iRhythm Technologies Raises US$3.5 Million In Venture Financing 74 7 Recent Developments 76 7.1 Corporate Communications 76 7.1.1 Apr 16, 2014: Proteus Digital Health Grows Leadership Team and Board of Directors with Former Executives from Novartis, Microsoft and Egreetings Network 76 Read Complete Report with TOC: http://www.radiantinsights.com/research/united-statescardiac-rhythm-management-market-outlook-to-2020 7.1.2 Apr 08, 2014: Ventripoint Corporate Update and Resignation of Director 76 7.1.3 Feb 18, 2014: SurModics Announces Changes to Board of Directors 77 7.1.4 Feb 14, 2014: Stereotaxis Appoints William C. Mills III to Chief Executive Officer 78 7.1.5 Jan 06, 2014: Catalyst Pharmaceutical Partners Reports Successful Completion of Type B Breakthrough Therapy Meeting With FDA on Firdapse Tablets Development Program 79 7.1.6 Dec 05, 2013: Anxious Patient Group Calls on NICE to Approve Only Drug Treatment for Ultra-Rare Disease 80 7.1.7 Nov 04, 2013: Canbex Therapeutics Commences Phase I Clinical Trial of Lead Product VSN16R as a Potential Treatment for Spasticity in Multiple Sclerosis 82 7.1.8 Sep 25, 2013: Accellent Announces the Promotion of Jeremy Friedman to President and Chief Operating Officer for the Cardio & Vascular Business and the Appointment of Richard Johnson as Interim CFO 82 7.1.9 Sep 20, 2013: SurModics Announces Board Changes 83 7.1.10 Sep 16, 2013: Arena Pharmaceuticals Provides Update as Eisai's Launch of BELVIQ CIV Enters Consumer Phase 83 7.1.11 Aug 19, 2013: Orthofix Receives Expected NASDAQ Notice Related to Late Filing of Form 10-Q 84 7.1.12 Aug 16, 2013: Stereotaxis Announces Listing Transfer to NASDAQ Capital Market 84 7.1.13 Aug 02, 2013: China CDC Enters Into R&D Agreement With Aeras Global For TB Vaccine 84 7.1.14 Jul 23, 2013: Dean Schauer, Executive Vice President, Cardio & Vascular Group, Announces Resignation 86
7.1.15 Jul 02, 2013: InSite Vision Receives Notice of Allowance from USPTO for Patent on DuraSite 2 Ophthalmic Drug Delivery System 86 7.2 Financial Announcements 87 7.2.1 May 06, 2014: Stereotaxis Reports 2014 First Quarter Financial Results 87 7.2.2 May 01, 2014: SurModics Reports Second Quarter Fiscal 2014 Results 88 7.2.3 Apr 22, 2014: Bard Announces First Quarter Results 90 7.2.4 Feb 25, 2014: Stereotaxis Reports 2013 Fourth Quarter and Full Year Financial Results 90 7.2.5 Feb 18, 2014: Medtronic Reports Third Quarter Earnings 92 7.2.6 Jan 30, 2014: Bard Announces Fourth Quarter Results 94 7.2.7 Jan 30, 2014: SurModics Reports First Quarter Fiscal 2014 Results 94 7.2.8 Dec 11, 2013: Bard Declares Quarterly Dividend 96 7.2.9 Nov 19, 2013: Medtronic Reports Second Quarter Earnings 96 7.2.10 Nov 14, 2013: Stereotaxis Reports Third Quarter 2013 Financial Results 98 7.2.11 Nov 11, 2013: Medtronic to Announce Financial Results for Its Second Quarter of Fiscal Year 2014 100 7.2.12 Nov 07, 2013: Accellent Announces Third Quarter 2013 Results 100 7.2.13 Nov 05, 2013: SurModics Reports Fourth Quarter and Full Year 2013 Results 101 7.2.14 Oct 29, 2013: SurModics to Webcast Fourth Quarter and Fiscal Year 2013 Earnings Conference Call on November 5 103 To Get Sample Copy of Report visit @ http://www.radiantinsights.com/research/unitedstates-cardiac-rhythm-management-market-outlook-to-2020#tabs-4 7.2.15 Oct 23, 2013: Stereotaxis Announces Preliminary Third Quarter 2013 Financial Results in Preparation for Rights Offering 103 7.2.16 Oct 22, 2013: Bard Announces Third Quarter Results 104 7.2.17 Oct 09, 2013: Bard Declares Quarterly Dividend 104 7.2.18 Oct 01, 2013: Bard to Host Earnings Conference Call on October 22, 2013 104 7.2.19 Aug 20, 2013: Medtronic Reports First Quarter Earnings 105 7.2.20 Aug 13, 2013: Accellent Announces Second Quarter 2013 Results 106 7.2.21 Aug 12, 2013: Medtronic to Announce Financial Results for Its First Quarter of Fiscal Year 2014 107 7.2.22 Aug 08, 2013: Stereotaxis Reports Second Quarter 2013 Financial Results; Announces Capital Transactions 108 7.2.23 Aug 06, 2013: Accellent Announces Timing of Second Quarter 2013 Earnings Release and Conference Call 110 7.2.24 Jul 31, 2013: SurModics Reports Third Quarter Fiscal 2013 Results 110 7.2.25 Jul 24, 2013: Bard Announces Second Quarter Results 112 7.2.26 Jul 23, 2013: SurModics to Webcast Third Quarter 2013 Earnings Conference Call on July 31 113 7.2.27 May 21, 2013: Medtronic Reports Revenue Of $16.6 Billion In Fiscal 2013 113 7.2.28 May 14, 2013: Accellent Reports Revenue Of $120.8m In Q1 2013 115 7.2.29 May 13, 2013: Stereotaxis Reports Revenue Of $8.4m In Q1 2013 115 7.3 Government and Public Interest 116
About Us Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of Ancillary services such as, research partnerships/ tie-ups and customized research solutions. Media Contact: Michelle Thoras Corporate Sales Specialist, USA Radiant Insights, Inc Phone: 1-415-349-0054 Toll Free: 1-888-202-9519 Email: sales@radiantinsights.com Website: Radiant Insights Visit Our Blog: radiantri.blogspot.com